Medicine safety communications

29 October 2020EMA

Quofenix / Quinsair: safety signal

Safety signalMedicine safety communications

29 October 2020EMA

Esbriet: type ii variation

Type II variationMedicine safety communications

23 September 2020EMA

Nulojix: medicine shortage

Medicine shortageMedicine safety communications

3 September 2020EMA

RoActemra: medicine shortage

Medicine shortageMedicine safety communications

20 July 2020EMA

Insuman: type ii variation

Type II variationMedicine safety communications

18 June 2020EMA

Suboxone: quality defect

Quality defectMedicine safety communications

18 June 2020EMA

Myalepta: quality defect

Quality defectMedicine safety communications

17 June 2020EMA

Ondexxya: safety signal

Safety signalMedicine safety communications

4 June 2020EMA

Xeloda / Capecitabine Accord / Capecitabine Medac / Capecitabine Teva / Ecansya (previously Capecitabine Krka) / Teysuno: referral - article 31

Referral - Article 31Medicine safety communications

4 June 2020EMA

Flucytosine: referral - article 31

Referral - Article 31Medicine safety communications

1 June 2020EMA

Tepadina: quality defect

Quality defectMedicine safety communications

12 May 2020EMA

Brivudine: periodic safety update single assessment

Periodic safety update single assessmentMedicine safety communications

23 March 2020EMA

Esmya / Ulipristal Acetate Gedeon Richter: interim measures

Interim measuresMedicine safety communications

25 February 2020EMA

Mepact: quality defect

Quality defectMedicine safety communications

20 February 2020EMA

Estradiol: referral - article 31

Referral - Article 31Medicine safety communications

27 January 2020EMA

Picato: interim measures;referral - article 20 procedure

Interim measures;Referral - Article 20 procedureMedicine safety communications

—EMA

Ecalta: quality defect

Quality defectMedicine safety communications

—EMA

Cyproterone: referral - article 31

Referral - Article 31Medicine safety communications

—EMA

Polivy: quality defect

Quality defectMedicine safety communications

—EMA

Prevymis

Medicine safety communications

—EMA

Leuprorelin: referral - article 31

Referral - Article 31Medicine safety communications

—EMA

Cabazitaxel Accord: medication error

Medication errorMedicine safety communications

—EMA

Spikevax (previously COVID-19 Vaccine Moderna): adverse event

Adverse eventMedicine safety communications

—EMA

Xalkori: adverse event

Adverse eventMedicine safety communications